Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Pharmacological study of protective mechanisms of thymoquinone in experimentally induced lung fibrosis

  • At: 2013 FIP Congress in Dublin (Ireland)
  • Type: Poster
  • By: EL-KHOULY, Dalia (Future University, Pharmacology and Toxicology, Cairo, Egypt)
  • Co-author(s): El-Bakly, Wesam (Faculty of Medicine, Cairo, Egypt)
    Awad, Azza (Faculty of Pharmacy, Cairo, Egypt)
    El-Mesallamy, Hala (Faculty of Pharmacy, Cairo, Egypt)
    El-Demerdash, Ebtehal (Faculty of Pharmacy, Cairo, Egypt)
  • Abstract:


    Background

    :Pulmonary fibrosis is one of the most common chronic interstitial lung diseases with high mortality rate after diagnosis and limited successful treatment
    .


    Aims:

    The present study was designed to assess the potential antifibrotic effect of thymoquinone (TQ) and whether TQ can attenuate the severity of oxidative stress and inflammatory


    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses